Skip to main content

Harshit Khadka

Analyst

RoboCapital

Equibles does not estimate personal net worth.

About Harshit Khadka

Harshit Khadka is recorded as Analyst at RoboCapital. Harshit Khadka has spoken on 3 earnings calls across 3 companies, most recently for Kiri Industries Limited on November 6, 2026. Those appearances were for Kiri Industries Limited, Rajshree Polypack Limited and Solara Active Pharma Sciences Limited. The companies whose calls Harshit Khadka spoke on are classified in the Basic Materials, Consumer Cyclical and Healthcare sectors.

Harshit Khadka on recent calls

“So, just wanted to understand, sir, what can be the peak revenue that we can achieve from a dive business?”
Analyst — RoboCapital, Earnings Call for the Quarter Ended September 30, 2026 ·
“Sir, just wanted to understand, like, given our current capacity, what can be the peak revenue that we can achieve?”
Analyst — RoboCapital, Earnings Call for the Quarter Ended September 30, 2026 ·
“It's good to see, you know, 15 plus percent EBITDA margins in Q4. I just wanted to understand, like, what kind of numbers can we achieve for FY27 and FY28 on revenue and EBITDA basis?”
Analyst — RoboCapital, Earnings Call for the Quarter Ended March 31, 2026 ·

Affiliation history

  • RoboCapital

    Analyst

    Transcript header (unverified)

    Current

Company network

Kiri Industries Limited

Specialty Chemicals · Basic Materials

1 appearance Latest appearance 2026-11-06

Rajshree Polypack Limited

Packaging & Containers · Consumer Cyclical

1 appearance Latest appearance 2026-11-04

Solara Active Pharma Sciences Limited

Drug Manufacturers - Specialty & Generic · Healthcare

1 appearance Latest appearance 2026-05-15

Recent activity

  • Earnings call

    Earnings Call for the Quarter Ended September 30, 2026

    Kiri Industries Limited

  • Earnings call

    Earnings Call for the Quarter Ended September 30, 2026

    Rajshree Polypack Limited

  • Earnings call

    Earnings Call for the Quarter Ended March 31, 2026

    Solara Active Pharma Sciences Limited